Lanzamiento Enero 2027

Ensayo controlado aleatorizado2024Acceso abierto

Impact of Short-Term Creatine Supplementation on Muscular Performance among Breast Cancer Survivors

Parsowith EJ, Stock MS, Kocuba O, Schumpp A, Jackson K, Brooks AM, Larson A, Dixon M, Fairman CM

Nutrients · 5 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Universidad u hospital
University of South Carolina
Universidad u hospital
University of South Carolina Magellan Award
Universidad u hospital
the University of South Carolina Magellan

Según 3 financiadores declarados y la declaración de financiación del texto completo.

Publicación

Publicado
2024-03-27 · Nutrients · vol. 16 · número 7 · pág. 979
Editorial
Multidisciplinary Digital Publishing Institute
Citado
9 citas · más que el 82% de estudios similares · 1.7× el promedio de su campo
Referencias
71 trabajos
Acceso
Acceso abierto (revista) · CC-BY
Áreas de investigación
Muscle metabolism and nutrition · Nutrition and Health in Aging · Cancer survivorship and care
Palabras clave
creatine supplementation, breast cancer survivors, muscle performance, muscle strength, muscle power, isokinetic peak torque, isometric peak torque, 10-repetition maximum, dextrose placebo, muscle mass loss
MeSH
humans, breast neoplasms, creatine, polyesters, dietary supplements, aged, middle aged, survivors, female, cancer survivors

9 autores

  • Emily J. Parsowith🇺🇸University of Central Florida
  • Matt S. Stock🇺🇸University of Central Florida
  • Olivia R. Kocuba🇺🇸University of South Carolina
  • Alec Schumpp🇺🇸University of South Carolina
  • Kylah E. Jackson🇺🇸University of South Carolina
  • Alexander M. Brooks🇺🇸University of South Carolina
  • Alena Larson🇺🇸University of South Carolina
  • Madison D. Dixon🇺🇸University of South Carolina
  • Ciaran M. Fairman🇺🇸 · autor de correspondenciaUniversity of South Carolina

Resumen

El texto original del estudio, en el idioma en que se publicó.

Breast cancer (BC) is one of the most common cancers in the United States. Advances in detection and treatment have resulted in an increased survival rate, meaning an increasing population experiencing declines in muscle mass and strength. Creatine supplementation has consistently demonstrated improvements in strength and muscle performance in older adults, though these findings have not been extended to cancer populations.

Purpose

The purpose of this study was to investigate the effects of short-term creatine supplementation on muscular performance in BC survivors.

Methods

Using a double-blind, placebo-controlled, randomized design, 19 female BC survivors (mean ± SD age = 57.63 ± 10.77 years) were assigned to creatine (SUPP) (n = 9) or dextrose placebo (PLA) (n = 10) groups. The participants completed two familiarization sessions, then two test sessions, each separated by 7 days, where the participants supplemented with 5 g of SUPP or PLA 4 times/day between sessions. The testing sessions included sit-to-stand power, isometric/isokinetic peak torque, and upper/lower body strength via 10 repetition maximum (10RM) tests. The interaction between supplement (SUPP vs. PLA) and time (Pre vs. Post) was examined using a group × time ANOVA and effect sizes.

Results

No significant effects were observed for sit-to-stand power (p = 0.471; ηp2 = 0.031), peak torque at 60°/second (p = 0.533; ηp2 = 0.023), peak torque at 120°/second (p = 0.944; ηp2 p = 0.905; ηp2 p = 0.407; ηp2 = 0.041), and 10RM leg extension (p = 0.932; ηp2 p2 = 0.531) and leg extension (ηp2 = 0.422).

Conclusion

Seven days of creatine supplementation does not influence muscular performance among BC survivors.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.